Rongkuan Hu
- Cancer Research top 5%
- MicroRNA in disease regulation 6
-
- Circular RNAs in diseases 4
- Extracellular vesicles in disease 2
- Metabolism, Diabetes, and Cancer 2
-
- Peptidase Inhibition and Analysis 2
-
- Immunotherapy and Immune Responses 2
-
- Viral gastroenteritis research and epidemiology 1
-
- Surfactants and Colloidal Systems 1
- Partner nations
- ChinaUnited States
In The Last Decade
Rongkuan Hu
17 papers receiving 612 citations
Peers
Comparison fields: 5 of 75
- Cancer Research 323
- Molecular Biology 455
- Pharmaceutical Science 25
- Oncology 87
- Biomaterials 38
Countries citing papers authored by Rongkuan Hu
This map shows the geographic impact of Rongkuan Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rongkuan Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rongkuan Hu more than expected).
Fields of papers citing papers by Rongkuan Hu
This network shows the impact of papers produced by Rongkuan Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rongkuan Hu. The network helps show where Rongkuan Hu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Rongkuan Hu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 7 | |
| 3 | 2021 | 30 | |
| 4 | 2021 | 8 | |
| 5 | 2020 | 19 | |
| 6 | 2020 | 22 | |
| 7 | 2019 | 28 | |
| 8 | 2019 | 63 | |
| 9 | 2018 | 7 | |
| 10 | 2018 | 98 | |
| 11 | 2018 | 7 | |
| 12 | 2018 | 75 | |
| 13 | 2017 | 82 | |
| 14 | 2017 | 28 | |
| 15 | 2016 | 47 | |
| 16 | 2013 | 31 | |
| 17 | 2012 | 65 |
About Rongkuan Hu
Rongkuan Hu is a scholar working on Cancer Research, Molecular Biology and Oncology, having authored 17 papers that have together received 618 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (6 papers), Circular RNAs in diseases (4 papers), Extracellular vesicles in disease (2 papers), Peptidase Inhibition and Analysis (2 papers), Immunotherapy and Immune Responses (2 papers), Metabolism, Diabetes, and Cancer (2 papers), Viral gastroenteritis research and epidemiology (1 paper) and Surfactants and Colloidal Systems (1 paper). The work is most often cited by research in Cancer Research (323 citations), Molecular Biology (455 citations) and Pharmaceutical Science (25 citations). Rongkuan Hu has collaborated with scholars based in China and United States. Frequent co-authors include Xiaofeng Xue, Xiaona Wang, Lei Qin, Xiaoyan Fei, Yajie Zhang, Liu Liu, Wenjie Hou, Hai‐Yang Liu, Jiarui Wu and Huan Yan. Their work appears in journals such as Nature Communications, PLoS ONE and Biomaterials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.